GENIE, which stands for Genomics Evidence Neoplasia Information Exchange, is a publicly accessible international cancer registry of real-world data assembled by the AACR through data sharing between 19 of the leading cancer centers in the world.

Project GENIE is in its seventh year and the number of users continues to grow. The project will be accepting applications for new consortium participating institutions this year. Watch the video below to learn more.

Nivolumab/chemo combo will change lung cancer care
A new study that pairs neoadjuvant nivolumab with chemotherapy for patients with nonsmall cell lung cancer has the potential to revolutionize treatment,...

AACR 2022 video: AACR taskforce tackles public trust in science
NEW ORLEANS -- On day four of the American Association for Cancer Research (AACR) meeting, ScienceBoard.net spoke with Dr. Jesse Nodora, PhD,...

CAR T-cells show preliminary efficacy, safety as solid-tumor treatment
Researchers presented phase I/II preliminary clinical trial data demonstrating the safety and efficacy of a new CAR T-cell therapy that can be used as...

Video from AACR 2022: Does the microbiome predict precervical cancer risk?
NEW ORLEANS - Does the microbiome provide clues to the precervical cancer risk of women? This is the question that Katherine Tossas, PhD, is investigating....

Video from AACR 2022: Next-gen pathology tools for cancer research
NEW ORLEANS - What do the next-generation of pathology tools for cancer research look like, and how can pathologists contribute to those technologies...